These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Warren CA; van Opstal E; Ballard TE; Kennedy A; Wang X; Riggins M; Olekhnovich I; Warthan M; Kolling GL; Guerrant RL; Macdonald TL; Hoffman PS Antimicrob Agents Chemother; 2012 Aug; 56(8):4103-11. PubMed ID: 22585229 [TBL] [Abstract][Full Text] [Related]
9. Aryl-alkyl-lysines: Novel agents for treatment of C. difficile infection. Ghosh C; AbdelKhalek A; Mohammad H; Seleem MN; Haldar J Sci Rep; 2020 Mar; 10(1):5624. PubMed ID: 32221399 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability? Chiu CW; Tsai PJ; Lee CC; Ko WC; Hung YP J Microbiol Immunol Infect; 2021 Dec; 54(6):1011-1017. PubMed ID: 34229970 [TBL] [Abstract][Full Text] [Related]
11. Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis. Spinler JK; Auchtung J; Brown A; Boonma P; Oezguen N; Ross CL; Luna RA; Runge J; Versalovic J; Peniche A; Dann SM; Britton RA; Haag A; Savidge TC Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760934 [TBL] [Abstract][Full Text] [Related]
12. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates. Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Knight EM; Schiller DS; Fulman MK; Rastogi R J Pharm Pract; 2020 Oct; 33(5):633-639. PubMed ID: 30744479 [TBL] [Abstract][Full Text] [Related]
14. Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin Susceptibility. Greentree DH; Rice LB; Donskey CJ Clin Infect Dis; 2022 Oct; 75(9):1661-1664. PubMed ID: 35653393 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anti-clostridial activity of newly isolated Pediococcus acidilactici SPM138 against Clostridium difficile. Choi MK; Choi S Anaerobe; 2020 Feb; 61():102146. PubMed ID: 31887433 [TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection. Stevens VW; Nelson RE; Schwab-Daugherty EM; Khader K; Jones MM; Brown KA; Greene T; Croft LD; Neuhauser M; Glassman P; Goetz MB; Samore MH; Rubin MA JAMA Intern Med; 2017 Apr; 177(4):546-553. PubMed ID: 28166328 [TBL] [Abstract][Full Text] [Related]
17. Polyethylene glycol intestinal lavage in addition to usual antibiotic treatment for severe McCreery G; Jones PM; Kidane B; DeMelo V; Mele T; BMJ Open; 2017 Jul; 7(7):e016803. PubMed ID: 28760801 [TBL] [Abstract][Full Text] [Related]
18. Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. Chen J; Li J; Wu L; Geng Y; Yu J; Chong C; Wang M; Gao Y; Bai C; Ding Y; Chen Y; Zhang Q Eur J Med Chem; 2018 May; 151():601-627. PubMed ID: 29656202 [TBL] [Abstract][Full Text] [Related]
19. Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection. McPherson J; Hu C; Begum K; Wang W; Lancaster C; Gonzales-Luna AJ; Loveall C; Silverman MH; Alam MJ; Garey KW Antimicrob Agents Chemother; 2022 Aug; 66(8):e0224421. PubMed ID: 35862742 [TBL] [Abstract][Full Text] [Related]
20. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum. Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]